| Literature DB >> 23473657 |
J G Weinkauf1, L Puttagunta, R Nador, K Jackson, K LaBranche, A Kapasi, J Mullen, D L Modry, K C Stewart, M Thakrar, K Doucette, D C Lien.
Abstract
Talc lung granulomatosis results from the intravenous use of medication intended for oral use. Talc (magnesium silicate) acts as filler in some oral medications; when injected intravenously, it deposits in the lungs leading to airflow obstruction and impaired gas exchange. Allocation of donor lungs to previous intravenous drug users is controversial. After a careful selection process, 19 patients with talc lung granulomatosis have received lung allografts in our program. Long-term survival for these patients is excellent and our results suggest the previous use of intravenous drugs should not necessarily preclude lung transplantation.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23473657 DOI: 10.1016/j.transproceed.2012.11.004
Source DB: PubMed Journal: Transplant Proc ISSN: 0041-1345 Impact factor: 1.066